Neurovalens
PrivateLast Round
Early Funding
Aug 19, 2025
Total Funding Raised
$25.37M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neurovalens is a health-technology company that develops non-invasive neurostimulation products to address global health issues.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, Health IoT, Clinical Trials
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurovalens Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Neurovalens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 19, 2025 | ||||
| VC Round | Aug 19, 2025 | ||||
| Series A Extension | Apr 8, 2024 | ||||
| Debt | Jan 21, 2022 | ||||
| Grant | Sep 1, 2021 | ||||
VC Round | Jul 20, 2020 |
Key People
Founding team and executive leadership
Neurovalens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACF Investors | VC Round, Early Funding |
| MedTech Innovator | Series A Extension |
| Future Fund | VC Round |
| Whiterock Finance | VC Round, Early Funding, Debt |
| British Business Bank | Series A Extension, Series A, Early Funding |
| Invest Northern Ireland | Series A Extension, Grant |
| IQ Capital | VC Round, Series A Extension, Series A, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 19, 2025
$7M round led by Investment Fund for Northern Ireland.
- Aug 19, 2025
$8.1M raised in early funding.
Neurovalens Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurovalens's valuation, stock price, and market status.